It looks like you're accessing our website from North America. We have a dedicated page tailored to your region, offering the most relevant information and services.
If you have an existing eCom account, you can log in to the North American site using your current username and password.
Would you like to visit the North America page?
You can access the page here
PCT is considered to be the main marker of disorders that are accompanied by systemic inflammation and sepsis.
For the development of PCT immunoassays
we offer monoclonal antibodies
that
are specific to different fragments
of the PCT molecule.
Procalcitonin (PCT) is a small protein that is synthesized by the C-cells in thyroid glands. In cells, PCT is further cleaved into three molecules: N-terminal fragment (N-terminal PCT), calcitonin and katacalcin.
PCT is considered to be the main marker of disorders that are accompanied by systemic inflammation and sepsis. In addition to sepsis and infection, the level of PCT can increase e.g. as a result of surgery, polytrauma, heat shock, burn injuries or cardiogenic shock. Monitoring PCT levels after cardiac surgery or heart transplantation helps to differentiate an acute graft rejection from bacterial or fungal infections.
For the development of PCT immunoassays we offer monoclonal antibodies that are specific to different fragments of the PCT molecule.
Learn more:
Cat# 4C10/4C10cc: Calcitonin, antibody
Cat# 4PC47: Procalcitonin, human, antibody
Cat# PPC3: Procalcitonin, polyclonal antibody